vs
Side-by-side financial comparison of EAST WEST BANCORP INC (EWBC) and STEPAN CO (SCL). Click either name above to swap in a different company.
EAST WEST BANCORP INC is the larger business by last-quarter revenue ($774.0M vs $604.5M, roughly 1.3× STEPAN CO). EAST WEST BANCORP INC runs the higher net margin — 46.3% vs 3.3%, a 43.0% gap on every dollar of revenue. On growth, EAST WEST BANCORP INC posted the faster year-over-year revenue change (11.8% vs 1.9%). Over the past eight quarters, EAST WEST BANCORP INC's revenue compounded faster (18.3% CAGR vs 4.2%).
East West Bank is an American bank that is the primary subsidiary of East West Bancorp. It is the largest publicly traded bank headquartered in Southern California. The company has been ranked the #1 performing U.S. bank with more than $10 billion in assets by S&P Global Market Intelligence, and the top performing bank in its asset size by Bank Director for three straight years since 2023.
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
EWBC vs SCL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $774.0M | $604.5M |
| Net Profit | $358.0M | $19.7M |
| Gross Margin | — | 10.7% |
| Operating Margin | — | 4.7% |
| Net Margin | 46.3% | 3.3% |
| Revenue YoY | 11.8% | 1.9% |
| Net Profit YoY | 0.4% | — |
| EPS (diluted) | $2.57 | $0.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $774.0M | $604.5M | ||
| Q4 25 | $657.8M | $553.9M | ||
| Q3 25 | $677.5M | $590.3M | ||
| Q2 25 | $617.1M | $594.7M | ||
| Q1 25 | $600.2M | $593.3M | ||
| Q4 24 | $587.6M | $525.6M | ||
| Q3 24 | $572.7M | $546.8M | ||
| Q2 24 | $553.2M | $556.4M |
| Q1 26 | $358.0M | $19.7M | ||
| Q4 25 | $356.3M | $5.0M | ||
| Q3 25 | $368.4M | $10.8M | ||
| Q2 25 | $310.3M | $11.3M | ||
| Q1 25 | $290.3M | $19.7M | ||
| Q4 24 | $293.1M | $3.4M | ||
| Q3 24 | $299.2M | $23.6M | ||
| Q2 24 | $288.2M | $9.5M |
| Q1 26 | — | 10.7% | ||
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 12.7% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 12.5% |
| Q1 26 | — | 4.7% | ||
| Q4 25 | 71.0% | 1.9% | ||
| Q3 25 | 68.6% | 3.7% | ||
| Q2 25 | 65.2% | 3.0% | ||
| Q1 25 | 65.2% | 4.8% | ||
| Q4 24 | 60.6% | 1.5% | ||
| Q3 24 | 68.0% | 4.4% | ||
| Q2 24 | 65.9% | 3.4% |
| Q1 26 | 46.3% | 3.3% | ||
| Q4 25 | 54.2% | 0.9% | ||
| Q3 25 | 54.4% | 1.8% | ||
| Q2 25 | 50.3% | 1.9% | ||
| Q1 25 | 48.4% | 3.3% | ||
| Q4 24 | 49.9% | 0.6% | ||
| Q3 24 | 52.2% | 4.3% | ||
| Q2 24 | 52.1% | 1.7% |
| Q1 26 | $2.57 | $0.86 | ||
| Q4 25 | $2.55 | $0.22 | ||
| Q3 25 | $2.65 | $0.47 | ||
| Q2 25 | $2.24 | $0.50 | ||
| Q1 25 | $2.08 | $0.86 | ||
| Q4 24 | $2.10 | $0.14 | ||
| Q3 24 | $2.14 | $1.03 | ||
| Q2 24 | $2.06 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $328.4M |
| Stockholders' EquityBook value | $9.0B | $1.2B |
| Total Assets | $82.9B | $2.3B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $132.7M | ||
| Q3 25 | $4.7B | $118.5M | ||
| Q2 25 | $4.4B | $88.9M | ||
| Q1 25 | $3.4B | $107.5M | ||
| Q4 24 | $5.3B | $99.7M | ||
| Q3 24 | $4.9B | $147.3M | ||
| Q2 24 | $4.4B | $124.7M |
| Q1 26 | — | $328.4M | ||
| Q4 25 | $35.6M | $626.7M | ||
| Q3 25 | $35.7M | $655.5M | ||
| Q2 25 | $35.8M | $658.0M | ||
| Q1 25 | $35.9M | $659.3M | ||
| Q4 24 | $36.0M | $625.4M | ||
| Q3 24 | $36.1M | $688.5M | ||
| Q2 24 | $36.1M | $657.1M |
| Q1 26 | $9.0B | $1.2B | ||
| Q4 25 | $8.9B | $1.2B | ||
| Q3 25 | $8.6B | $1.2B | ||
| Q2 25 | $8.2B | $1.2B | ||
| Q1 25 | $7.9B | $1.2B | ||
| Q4 24 | $7.7B | $1.2B | ||
| Q3 24 | $7.7B | $1.2B | ||
| Q2 24 | $7.2B | $1.2B |
| Q1 26 | $82.9B | $2.3B | ||
| Q4 25 | $80.4B | $2.4B | ||
| Q3 25 | $79.7B | $2.4B | ||
| Q2 25 | $78.2B | $2.4B | ||
| Q1 25 | $76.2B | $2.4B | ||
| Q4 24 | $76.0B | $2.3B | ||
| Q3 24 | $74.5B | $2.4B | ||
| Q2 24 | $72.5B | $2.3B |
| Q1 26 | — | 0.28× | ||
| Q4 25 | 0.00× | 0.50× | ||
| Q3 25 | 0.00× | 0.53× | ||
| Q2 25 | 0.00× | 0.53× | ||
| Q1 25 | 0.00× | 0.55× | ||
| Q4 24 | 0.00× | 0.53× | ||
| Q3 24 | 0.00× | 0.56× | ||
| Q2 24 | 0.01× | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EWBC
Segment breakdown not available.
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
